Free Trial

Monogram Orthopaedics (MGRM) Competitors

Monogram Orthopaedics logo
$2.97 -0.08 (-2.59%)
Closing price 03:58 PM Eastern
Extended Trading
$2.86 -0.12 (-3.90%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MGRM vs. NPCE, CLPT, TCMD, SMLR, NNOX, STIM, SMTI, ZIMV, RCEL, and SNWV

Should you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include NeuroPace (NPCE), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Semler Scientific (SMLR), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry.

Monogram Orthopaedics vs.

NeuroPace (NASDAQ:NPCE) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

NeuroPace received 28 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 75.00% of users gave Monogram Orthopaedics an outperform vote while only 60.78% of users gave NeuroPace an outperform vote.

CompanyUnderperformOutperform
NeuroPaceOutperform Votes
31
60.78%
Underperform Votes
20
39.22%
Monogram OrthopaedicsOutperform Votes
3
75.00%
Underperform Votes
1
25.00%

Monogram Orthopaedics has a net margin of 0.00% compared to NeuroPace's net margin of -36.74%. Monogram Orthopaedics' return on equity of -130.90% beat NeuroPace's return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroPace-36.74% -205.41% -28.29%
Monogram Orthopaedics N/A -130.90%-106.38%

Monogram Orthopaedics has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Monogram Orthopaedics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroPace$79.91M4.79-$32.96M-$0.95-12.31
Monogram Orthopaedics$365.00K294.88-$13.74M-$0.46-6.63

NeuroPace has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.

78.8% of NeuroPace shares are held by institutional investors. Comparatively, 0.4% of Monogram Orthopaedics shares are held by institutional investors. 22.2% of NeuroPace shares are held by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, NeuroPace had 3 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 4 mentions for NeuroPace and 1 mentions for Monogram Orthopaedics. NeuroPace's average media sentiment score of 1.59 beat Monogram Orthopaedics' score of 0.62 indicating that NeuroPace is being referred to more favorably in the media.

Company Overall Sentiment
NeuroPace Very Positive
Monogram Orthopaedics Positive

NeuroPace presently has a consensus price target of $15.20, suggesting a potential upside of 30.03%. Monogram Orthopaedics has a consensus price target of $5.40, suggesting a potential upside of 77.05%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, analysts plainly believe Monogram Orthopaedics is more favorable than NeuroPace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroPace
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Monogram Orthopaedics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Summary

Monogram Orthopaedics beats NeuroPace on 11 of the 19 factors compared between the two stocks.

Get Monogram Orthopaedics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGRM vs. The Competition

MetricMonogram OrthopaedicsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$107.63M$4.39B$5.56B$7.83B
Dividend YieldN/A39.94%5.11%4.22%
P/E Ratio-6.4930.6722.4418.48
Price / Sales294.8854.91393.95103.59
Price / CashN/A51.0838.1834.62
Price / Book7.096.116.774.25
Net Income-$13.74M$68.15M$3.22B$248.23M
7 Day Performance6.64%-0.12%1.45%0.89%
1 Month Performance3.74%-2.24%3.96%3.53%
1 Year Performance56.41%24.15%16.07%5.08%

Monogram Orthopaedics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGRM
Monogram Orthopaedics
2.4578 of 5 stars
$2.97
-2.6%
$5.40
+81.8%
+47.7%$104.84M$364,999.00-6.3228
NPCE
NeuroPace
3.872 of 5 stars
$10.54
-2.3%
$15.20
+44.2%
-10.0%$343.18M$79.91M-10.54170Upcoming Earnings
Short Interest ↓
Positive News
CLPT
ClearPoint Neuro
2.1032 of 5 stars
$11.95
-2.4%
$25.00
+109.2%
+165.0%$334.36M$31.39M-17.32110
TCMD
Tactile Systems Technology
2.9504 of 5 stars
$13.45
+0.9%
$18.00
+33.8%
+2.5%$318.31M$292.98M19.21980Upcoming Earnings
SMLR
Semler Scientific
3.1054 of 5 stars
$29.83
-8.2%
$71.00
+138.0%
+26.6%$286.28M$56.29M6.08120Upcoming Earnings
Gap Up
NNOX
Nano-X Imaging
2.5797 of 5 stars
$4.75
-8.7%
$12.00
+152.6%
-43.9%$274.45M$11.28M-5.59190Positive News
STIM
Neuronetics
1.9817 of 5 stars
$3.88
+3.2%
$5.50
+41.8%
+30.0%$255.36M$74.89M-3.15180Upcoming Earnings
News Coverage
SMTI
Sanara MedTech
2.0274 of 5 stars
$28.66
-2.6%
$48.50
+69.2%
+0.3%$255.13M$86.67M-28.9560News Coverage
Positive News
ZIMV
ZimVie
2.6694 of 5 stars
$8.92
-5.0%
$19.50
+118.6%
-40.4%$248.40M$449.75M-0.682,700Positive News
RCEL
AVITA Medical
1.6955 of 5 stars
$9.10
-1.2%
$17.25
+89.6%
+15.4%$240.56M$64.25M-3.81130Upcoming Earnings
Positive News
SNWV
SANUWAVE Health
N/A$28.00
-6.6%
N/AN/A$239.37M$32.63M-7.1840

Related Companies and Tools


This page (NASDAQ:MGRM) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners